Singtel stock gains healthcare AI partnership with NUHS, Ericsson

Singtel, NUHS and Ericsson are expanding their healthcare technology partnership with a new research and development platform focused on connected care, artificial intelligence and next-generation mobile networks. The parties signed a memorandum of understanding on Nov. 3, 2026, according to a PR Newswire release published by Yahoo Finance.

New centre targets clinical applications

Singtel and Ericsson will become founding partners of the National University XG AI Centre, or NXAC, established by the National University Health System. The centre is intended to move emerging connectivity and AI technologies from research into practical healthcare applications and to test them in a working hospital environment.

The partners plan to work with clinicians, nurses and hospital operations teams. Areas under consideration include ambient AI for clinical workflows, spatial intelligence, connected medical devices, hospital-at-home services, autonomous robots, digital twins and medical extended reality.

From 5G-Advanced toward 6G

The programme will initially use 5G and 5G-Advanced capabilities, with a longer-term path toward early 6G. The release says the NXAC is intended to be the world's first 6G AI centre dedicated to healthcare. That claim comes from the partnership announcement and has not been tied to revenue guidance or a financial target.

For Singtel, the initiative reinforces the group's strategy of combining telecoms infrastructure with digital and AI services. The commercial effect remains dependent on whether research projects develop into deployable applications and customer contracts. The announcement itself contains no investment figure, earnings forecast or timetable for revenue contribution.

Singtel Singapore CEO Ng Tian Chong said the company would contribute network and digital capabilities as Singapore addresses an ageing population and more complex healthcare needs. Ericsson said its role would include research and advanced network capabilities for applications such as remote monitoring, robotic surgery and clinical collaboration.

The Singapore market remains the relevant trading backdrop for Singtel stock. Current market reports provide the broader regional context.

Further development will depend on joint training, fellowships, research funding and trials in healthcare facilities. More news and analyses on Singtel stock cover the company's other strategic initiatives.